|
|
|||
|
Home /
Thalassemia /
About Ja
/
Fund-Raisers
/
Events /
Guestbook
/
Donations /
Videos /
Gallery /
Press Review
/
Translator
/
E-Mail |
|||
|
Browse by month
2007: July / June / May / April / March / February / January / 2006: December / November / October / All months together |
|||
| Thalassemia | |||
|
How does it feel to discover that your child suffers from thalassemia? How does it feel to discover that your child will need intravenous medication 12 hours every day for the rest of his waking life? What would you do if you learnt that he would need a blood transfusion once every three weeks for the rest of his life?... About Thalassemia
About 150,000 babies worldwide are born with severe forms of the disease each year. Thalassemia occurs most frequently in people of Italian, Greek, Middle Eastern, Southern Asian and African ancestry. Recent publications indicate that, with modern supportive therapy, 32 percent of patients with thalassemia major will die by the age of 35.
How does one get Thalassemia?
It is not contagious and does not develop later in life, nor can a child outgrow it. Both parents must have the thalassemia trait in order to pass the disease on to their child. How can you prevent this?
Today, it is possible to precisely diagnose before three months of pregnancy (between 9 and 11 weeks), whether the fetus is normal, is a carrier (thalassemia minor) or has the disease (thalassemia major). The parents then have the option of terminating the pregnancy if the fetus is diagnosed as a beta thalassemia major. To Be tested, your doctor must order a blood test called "HEMOGLOBIN ELECTROPHORESIS", which can identify a carrier of thalassemia. How is Thalassemia treated?
Iron chelation is the only effective therapy for removing excess iron from the heart. Until recently, the only chelator available was Desferal, a drug that must be injected under the skin for 8-12 hours, for 5-7 nights per week. Ferriprox, the first iron chelator which can be given by mouth, is currently approved in 48 countries, including the European Union, for the treatment of iron overload in patients with thalassemia major for whom deferoxamine therapy is contra-indicated or who present serious toxicity with deferoxamine therapy. Ferriprox has not been approved for use in Canada Iron overload and iron chelation
What happens if a Thalassemic stops his medication?
Is there a permanent cure to Thalassemia?
Why Prevention "The hemoglobin disorders are the most common clinically serious single gene disorders in the world. It is estimated that over 300,000 affected children are born each year, most with sickle cell disease and with ß-thalassemia major. Most affected children are born in countries with limited resources, where priority tends to be given to tacking high rates of infant and child mortality from infections and malnutrition. As a result, hereditary disorders receive little attention and affected children do not receive the treatment they need, dying in childhood. The hemoglobin disorders in particular are often regarded as incurable and therefore "hopeless", and they are expensive to treat. Thalassemia patients may be left untreated (indeed, they often die without a diagnosis) or grossly under-treated. At the same time, quality of treatment is firmly linked to both survival rates and quality of life.
Online Links to Thalassemia Associations World Wide |
|||
|
Browse by month
2007: July / June / May / April / March / February / January / 2006: December / November / October / All months together
|
|||
|
|
|||